Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
64 hedge funds and large institutions have $314M invested in Amryt Pharma plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 10 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less funds holding
Funds holding: 68 → 64 (-4)
14% less capital invested
Capital invested by funds: $365M → $314M (-$51.7M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.83M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$2.13M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.77M |
| 4 |
AC
Armistice Capital
New York
|
+$1.39M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$468K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$9.93M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$3.86M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$1.2M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$510K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$311K |
AMYT Hedge Fund Activity: Q2 2022 in Review
64 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2022, worth a combined $314M — down 14% from $365M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AMYT and 6 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 17 added.
The largest buyer was Nantahala Capital Management, adding an estimated $3.83M. The largest seller was Man Group, exiting entirely with an estimated $9.93M sold.
- 64 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2022, down from 68 in Q1 2022.
- Funds reported $314M of Amryt Pharma plc American Depositary Shares stock for Q2 2022, down 14% quarter-over-quarter.
- 6 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2022 and 10 closed out, a net change of -4 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q2 2022 was Nantahala Capital Management, an estimated $3.83M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q2 2022 was Man Group, an estimated $9.93M sold.
Based on aggregated 13F filings for Q2 2022.